切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2023, Vol. 11 ›› Issue (04) : 233 -238. doi: 10.3877/cma.j.issn.2095-655X.2023.04.004

超声诊断

甲状腺滤泡状癌的超声及临床病理特征分析
努尔波勒, 马平, 诸玮()   
  1. 211300 南京市高淳人民医院超声科
    211300 南京市高淳人民医院病理科
  • 收稿日期:2022-12-31 出版日期:2023-11-26
  • 通信作者: 诸玮
  • 基金资助:
    江苏大学2021年临床医学科技发展基金项目(JLY2021173)

Ultrasonographic and clinicopathological features in patients with follicular thyroid cancer

Nuerbole, Ping Ma, Wei Zhu()   

  1. Department of Ultrasonography, Nanjing Gaochun People′s Hospital, Nanjing 211300, China
    Department of Pathology, Nanjing Gaochun People′s Hospital, Nanjing 211300, China
  • Received:2022-12-31 Published:2023-11-26
  • Corresponding author: Wei Zhu
引用本文:

努尔波勒, 马平, 诸玮. 甲状腺滤泡状癌的超声及临床病理特征分析[J/OL]. 中华诊断学电子杂志, 2023, 11(04): 233-238.

Nuerbole, Ping Ma, Wei Zhu. Ultrasonographic and clinicopathological features in patients with follicular thyroid cancer[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(04): 233-238.

目的

探讨甲状腺滤泡状癌(FTC)的超声及临床病理学特征。

方法

选择2019年6月15日至2022年12月31日于南京市高淳人医院超声科诊断的17例FTC患者,总结其超声、组织病理以及细针穿刺细胞学(FNAC)检查术后基因检测结果的特征。

结果

17例患者病灶长径为(31.23±15.44)mm。超声检查示所有患者肿块回声不均匀,均无微小钙化灶;76.47%(13/17)患者的超声学特点表现为肿块最大径大于25 mm,88.24%(15/17)的患者肿块可见血流信号,且其中70.59%(12/17)患者肿块内血流信号稀疏,82.35%(14/17)的患者肿块未见周围声晕;患者病灶弹性成像评分为(2.53±0.76)分。组织病理学结果显示所有病例的肿块都侵犯到了包膜及包膜外;免疫组织化学染色结果表明所有病例均为甲状腺转录因子1(TTF)阳性,降钙素阴性。9例患者进行FNAC后基因突变检测,鼠类肉瘤病毒癌基因(BRAF)突变检测均为阴性,其中6例患者进行端粒酶逆转录酶(TERT)基因突变检测,有5例为阳性。

结论

术后病理学检查仍然是诊断FTC的金标准,FNAC术联合分子标志物TERT的检测有助于提高FTC的术前诊断率。

Objective

To investigate the ultrasonographic and clinicopathological features of follicular thyroid cancer (FTC).

Methods

Seventeen patients diagnosed with FTC in the Ultrasonography Department of Nanjing Gaochun people′s Hospital between June 15, 2019 and December 31, 2022 were included to summarize the characteristics of ultrasonography, histopathology and gene testing results after fine needle aspiration cytology (FNAC) examination.

Results

The lesions in 17 patients had an average length diameter of (31.23±15.44)mm. Uneven echo and no microcalcification were visible on ultrasound. The maximum diameter of the mass exceeded than 25 mm in 76.47% (13/17) of the patients, 88.24% (15/17) of the patients could see the blood signal in the mass, 70.59% (12/17) of the patients had sparse blood signal, and 82.35% (14/17) of the patients had no surrounding sound halo. The patients received a focal elastic imaging score of (2.53±0.76) points. Histopathological findings revealed that the mass had invaded the capsule and extended outside of the capsule in each case. Immunohistochemical analysis showed that all instances were positive for thyroid transcription factor 1 (TTF) and negative for calcitonin. Nine individuals had the post FNAC gene mutation detection, while the B-Raf proto-oncogene serine/threonine kinase (BRAF) mutation was negative. In these patients, 6 patients had telomerase reverse transcriptase (TERT) gene mutation detection, of which 5 were positive.

Conclusions

Postoperative pathological examination is considered the gold standard for the diagnosis of FTC. However, the combination of FNAC and TERT detection can enhance the preoperative diagnostic accuracy of FTC.

表1 17例FTC患者病灶的超声特征
图1 甲状腺滤泡状癌的超声特征图像注:a图示甲状腺内等回声实性肿块,边界欠清晰,与甲状腺包膜分界欠清晰,内部回声不均匀,未见声晕,彩色多普勒血流显像(CDFI)示血流信号稀疏(箭头所示);b图示甲状腺内混合回声团块,边界欠清晰,与甲状腺包膜分界欠清晰,向包膜外突出,内部回声不均匀,CDFI见丰富的血流信号(箭头所示)
图2 甲状腺滤泡状癌病理特征图像注:a图示甲状腺右叶滤泡性肿瘤,见灶区包膜侵犯(HE× 10)(箭头所示); b图示降钙素免疫组织化学染色阴性(间接法× 10)
[1]
Qiu H, Cao S, Xu R.Cancer incidence,mortality,and burden in China:a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J].Cancer Commun (Lond)202141(10):1037-1048.DOI:10.1002/cac2.12197.
[2]
Kitahara CM, Sosa JA.The changing incidence of thyroid cancer[J].Nat Rev Endocrinol201612(11):646-653.DOI:10.1038/nrendo.2016.110.
[3]
Hoang JK, Lee WK, Lee M,et al.US Features of thyroid malignancy:pearls and pitfalls[J].Radiographics200727(3):847-865.DOI:10.1148/rg.273065038.
[4]
Scoazec JY, Couvelard A, Réseau TENpath. Classification of pancreatic neuroendocrine tumours:changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future[J].Ann Pathol201737(6):444-456.DOI:10.1016/j.annpat.2017.10.003.
[5]
Grani G, Lamartina L, Durante C,et al.Follicular thyroid cancer and Hürthle cell carcinoma:challenges in diagnosis,treatment,and clinical management[J].Lancet Diabetes Endocrinol20186(6):500-514.DOI:10.1016/S2213-8587(17)30325-X.
[6]
Itoh A, Ueno E, Tohno E,et al.Breast disease:clinical application of US elastography for diagnosis[J].Radiology2006239(2):341-350.DOI:10.1148/radiol.2391041676.
[7]
Zhou J, Yin L, Wei X,et al.2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules:the C-TIRADS[J].Endocrine202070(2):256-279.DOI:10.1007/s12020-020-02441-y.
[8]
Durante C, Grani G, Lamartina L,et al.The diagnosis and management of thyroid nodules:a review[J].JAMA2018319(9):914-924.DOI:10.1001/jama.2018.0898.
[9]
Choi SH, Kim EK, Kim SJ,et al.Thyroid ultrasonography:pitfalls and techniques[J].Korean J Radiol201415(2):267-276.DOI:10.3348/kjr.2014.15.2.267.
[10]
Lin Y, Lai S, Wang P,et al.Performance of current ultrasound-based malignancy risk stratification systems for thyroid nodules in patients with follicular neoplasms[J].Eur Radiol202232(6):3617-3630.DOI:10.1007/s00330-021-08450-3.
[11]
Jin M, Kim ES, Kim BH,et al.Clinical implication of world health organization classification in patients with follicular thyroid carcinoma in south korea:a multicenter cohort study[J].Endocrinol Metab (Seoul)202035(3):618-627.DOI:10.3803/EnM.2020.742.
[12]
Tessler FN, Middleton WD, Grant EG.Thyroid imaging reporting and data system (TI-RADS):a user's guide[J].Radiology2018287(1):29-36.DOI:10.1148/radiol.2017171240.
[13]
Daniels GH.Follicular thyroid carcinoma:a perspective[J].Thyroid201828(10):1229-1242.DOI:10.1089/thy.2018.0306.
[14]
黄美,吕国荣,苏毅明,等.滤泡性甲状腺癌超声误诊分析[J].中国超声医学杂志201935(10):865-868.DOI:10.3969/j.issn.1002-0101.2019.10.001.
[15]
Sillery JC, Reading CC, Charboneau JW,et al.Thyroid follicular carcinoma:sonographic features of 50 cases[J].AJR Am J Roentgenol2010194(1):44-54.DOI:10.2214/AJR.09.3195.
[16]
周树钧.甲状腺滤泡状癌的超声、临床病理特征及预后分析[D].福州:福建医科大学,2015.
[17]
Hahn SY, Shin JH, Ko EY,et al.Complementary role of elastography using carotid artery pulsation in the ultrasonographic assessment of thyroid nodules:a prospective study[J].Korean J Radiol201819(5):992-999.DOI:10.3348/kjr.2018.19.5.992.
[18]
Borowczyk M, Woliński K, Wiᶒckowska B, et al. Sonographic features differentiating follicular thyroid cancer from follicular adenoma-a meta-analysis[J].Cancers (Basel)202113(5):938.DOI:10.3390/cancers13050938.
[19]
Nikiforov YE.Molecular diagnostics of thyroid tumors[J].Arch Pathol Lab Med2011135(5):569-577.DOI:10.5858/2010-0664-RAIR.1.
[20]
Kakarmath S, Heller HT, Alexander CA,et al.Clinical,sonographic,and pathological characteristics of RAS-positive versus BRAF-positive thyroid carcinoma[J].J Clin Endocrinol Metab2016101(12):4938-4944.DOI:10.1210/jc.2016-2620.
[21]
段焕利.甲状腺肿瘤基因变异及其与临床病理特征、预后相关性的研究[D].北京:协和医学院,2019.
[22]
Pennelli G, Vianello F, Barollo S,et al.BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma[J].Thyroid201121(12):1393-1396.DOI:10.1089/thy.2011.0120.
[23]
Kim TH, Kim YE, Ahn S,et al.TERT promoter mutations and long-term survival in patients with thyroid cancer[J].Endocr Relat Cancer201623(10):813-823.DOI:10.1530/ERC-16-0219.
[24]
Proietti A, Sartori C, Macerola E,et al.Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms[J].Virchows Arch2017471(6):769-773.DOI:10.1007/s00428-017-2236-6.
[25]
Park H, Shin H C, Yang H,et al.Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations[J].Mod Pathol202235(2):186-192.DOI:10.1038/s41379-021-00907-6.
[26]
沙春艳.CK19,PCNA,VEGF,TTF-1在甲状腺滤泡性肿瘤中的表达及其意义[D].长春:吉林大学,2008.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[3] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[4] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[5] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[6] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[7] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[8] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[9] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[10] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[11] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[12] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[13] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?